Skip To Main Content
Frédéric Baron on Muck Rack

Frédéric Baron

As seen in: Nature, Wiley Online Library, Frontiers, MDPI, BioRxiv, Cell Press, The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Frédéric

Contact Frédéric, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS

|
By Tereza Coman, Stephane Morisset, Raynier Devillier, Maud D’Aveni, Frédéric Baron, Jacques Olivier Bay, Jean El-Cheikh, Claude-Eric Bulabois, Cristina Castilla-Llorente, Patrice Ceballos, Yves Chalandon, Sylvain Chantepie, Magalie Joris, Patrice Chevallier, Mustafa Alani, Jérôme Cornillon, Edouard Forcade, Gaelle Guillerm, Helene Labussière, Philippe Lewalle, Johan Maertens, Florent Malard, Jean-Valère Malfuson, Natacha Maillard, Jean Baptiste Mear, Stéphanie Nguyen-Quoc, Xavier Poiré, Marie-Thérèse Rubio, Felipe Suarez, Pascal Turlure, Alban Villate, Ibrahim Yakoub-Agha, Nicole Raus, Marie Robin, Anne Huynh, Mauricette Michallet, Karine Bilger, Etienne Daguindeau, Chama Mokeddem, Mikael Loschi, Cécile Pivert
| Nature Verified
Abstract Post-transplant cyclophosphamide (PTCy) has transformed graft-versus-host disease (GVHD) prophylaxis but its role in matched-donor reduced-intensity allogeneic hematopoietic cell transplantation (allo-HCT) remains uncertain.
Open in Who Shared Issue with article?

Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

|
By Arsène Mekinian, Artem Oganesyan, Zinaida Perić, Myriam Labopin, Urpu Salmenniemi, Anke Verlinden, Ioanna Sakellari, Mohsen Alzahrani, Massimo Martino, Frédéric Baron, John A Snowden, Hakan Ozdogu, Alexander Kulagin, Edgar Jost, Anna Torrent, Fabio Benedetti, Sylvie François, Montserrat Rovira, Hans Reinhardt, Alessandra Biffi, Nabil Yafour, Manuela Badoglio, Ivan S. Moiseev, Tobias Alexander, Mohamad Mohty Verified, Olivier Fain, Raffaella Greco, Olaf Penack, Anna De Becker, Mark Ringhoffer, Pascal Ambron, Alexandre Galvagni
| Nature Verified
Abstract Secondary autoimmune and inflammatory diseases (SAIDs) are underrecognized and poorly described after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The standardization of management is hindered by the scarcity of data on epidemiology, pathogenesis, and clinical outcomes.
Open in Who Shared Issue with article?

Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study - Bone Marrow Transplantation

|
By Malgorzata Mikulska, Gloria Tridello, Per Ljungman, Jan Styczynski, Diana Averbuch, Simone Cesaro, Nina Knelange, José Luis Piñana, Marina Popova, Nicolaus Kröger, Henrik Sengeloev, Caroline Besley, Hélène Labussiere-Wallet, Zeynep Yegin, Raffaella Greco, Frédéric Baron, Ipek Yonal-Hindilerden, Aliénor Xhaard, Elisabetta Metafuni, Jennifer Byrne, Selami Koçak Toprak, Anna Grassi, Daniele Vallisa, Jennifer Clay, Rodrigo Martino Bufarull, Gwendolyn van Gorkom, Omur Gokmen Sevindik, Keith Wilson, Lotus Wendel, Mareike Verbeek, Rafael de la Camara
| Nature Verified
COVID-19 has been associated with increased morbidity and mortality in immunocompromised patients due to inadequate control of the virus, resulting in higher risk of progression to severe disease, clinical and virological relapses and long time to viral elimination [1, 2]. Prolonged shedding of SARS-CoV-2 can also lead to delays in treatment of the underlying disease and viral evolution with the development of resistance [3,4,5].
Open in Who Shared Issue with article?
See all 21 articles